Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].

Identifieur interne : 000489 ( France/Analysis ); précédent : 000488; suivant : 000490

[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].

Auteurs : A. Toledano [France] ; P. Garaud ; D. Serin ; A. Fourquet ; J-F Bosset ; J. Miny-Buffet ; A. Favre ; D. Azria ; G. Body ; O. Le Floch ; G. Calais

Source :

RBID : pubmed:16632399

Descripteurs français

English descriptors

Abstract

In 1996, a multicenter randomized study comparing after breast-conservative surgery, sequential vs concurrent adjuvant chemotherapy (CT) with radiation therapy (RT) was initiated (ARCOSEIN study). Seven hundred sixteen patients were included in this trial. After a median follow-up of 6.7 (4.3-9) years, we decided to prospectively evaluate the late effects of these two strategies.

DOI: 10.1016/j.canrad.2006.03.001
PubMed: 16632399


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16632399

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].</title>
<author>
<name sortKey="Toledano, A" sort="Toledano, A" uniqKey="Toledano A" first="A" last="Toledano">A. Toledano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'Oncologie-Radiothérapie, Hôpital Tenon, APHP, Paris, France. alain.toledano@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Oncologie-Radiothérapie, Hôpital Tenon, APHP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garaud, P" sort="Garaud, P" uniqKey="Garaud P" first="P" last="Garaud">P. Garaud</name>
</author>
<author>
<name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D" last="Serin">D. Serin</name>
</author>
<author>
<name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
</author>
<author>
<name sortKey="Bosset, J F" sort="Bosset, J F" uniqKey="Bosset J" first="J-F" last="Bosset">J-F Bosset</name>
</author>
<author>
<name sortKey="Miny Buffet, J" sort="Miny Buffet, J" uniqKey="Miny Buffet J" first="J" last="Miny-Buffet">J. Miny-Buffet</name>
</author>
<author>
<name sortKey="Favre, A" sort="Favre, A" uniqKey="Favre A" first="A" last="Favre">A. Favre</name>
</author>
<author>
<name sortKey="Azria, D" sort="Azria, D" uniqKey="Azria D" first="D" last="Azria">D. Azria</name>
</author>
<author>
<name sortKey="Body, G" sort="Body, G" uniqKey="Body G" first="G" last="Body">G. Body</name>
</author>
<author>
<name sortKey="Le Floch, O" sort="Le Floch, O" uniqKey="Le Floch O" first="O" last="Le Floch">O. Le Floch</name>
</author>
<author>
<name sortKey="Calais, G" sort="Calais, G" uniqKey="Calais G" first="G" last="Calais">G. Calais</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16632399</idno>
<idno type="pmid">16632399</idno>
<idno type="doi">10.1016/j.canrad.2006.03.001</idno>
<idno type="wicri:Area/PubMed/Corpus">003A20</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A20</idno>
<idno type="wicri:Area/PubMed/Curation">003A20</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003A20</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003A20</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003A20</idno>
<idno type="wicri:Area/Ncbi/Merge">002201</idno>
<idno type="wicri:Area/Ncbi/Curation">002201</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002201</idno>
<idno type="wicri:doubleKey">1278-3218:2006:Toledano A:concurrent:administration:of</idno>
<idno type="wicri:Area/Main/Merge">007952</idno>
<idno type="wicri:Area/Main/Curation">007785</idno>
<idno type="wicri:Area/Main/Exploration">007785</idno>
<idno type="wicri:Area/France/Extraction">000489</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].</title>
<author>
<name sortKey="Toledano, A" sort="Toledano, A" uniqKey="Toledano A" first="A" last="Toledano">A. Toledano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'Oncologie-Radiothérapie, Hôpital Tenon, APHP, Paris, France. alain.toledano@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Oncologie-Radiothérapie, Hôpital Tenon, APHP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garaud, P" sort="Garaud, P" uniqKey="Garaud P" first="P" last="Garaud">P. Garaud</name>
</author>
<author>
<name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D" last="Serin">D. Serin</name>
</author>
<author>
<name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
</author>
<author>
<name sortKey="Bosset, J F" sort="Bosset, J F" uniqKey="Bosset J" first="J-F" last="Bosset">J-F Bosset</name>
</author>
<author>
<name sortKey="Miny Buffet, J" sort="Miny Buffet, J" uniqKey="Miny Buffet J" first="J" last="Miny-Buffet">J. Miny-Buffet</name>
</author>
<author>
<name sortKey="Favre, A" sort="Favre, A" uniqKey="Favre A" first="A" last="Favre">A. Favre</name>
</author>
<author>
<name sortKey="Azria, D" sort="Azria, D" uniqKey="Azria D" first="D" last="Azria">D. Azria</name>
</author>
<author>
<name sortKey="Body, G" sort="Body, G" uniqKey="Body G" first="G" last="Body">G. Body</name>
</author>
<author>
<name sortKey="Le Floch, O" sort="Le Floch, O" uniqKey="Le Floch O" first="O" last="Le Floch">O. Le Floch</name>
</author>
<author>
<name sortKey="Calais, G" sort="Calais, G" uniqKey="Calais G" first="G" last="Calais">G. Calais</name>
</author>
</analytic>
<series>
<title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title>
<idno type="ISSN">1278-3218</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Antineoplastic Agents (administration & dosage)</term>
<term>Antineoplastic Agents, Alkylating (administration & dosage)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Atrophy</term>
<term>Breast (drug effects)</term>
<term>Breast (radiation effects)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Chemotherapy, Adjuvant (adverse effects)</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Dose Fractionation</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Mitoxantrone (administration & dosage)</term>
<term>Prospective Studies</term>
<term>Radiotherapy, Adjuvant (adverse effects)</term>
<term>Single-Blind Method</term>
<term>Skin Pigmentation (drug effects)</term>
<term>Skin Pigmentation (radiation effects)</term>
<term>Telangiectasis (chemically induced)</term>
<term>Telangiectasis (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Antinéoplasiques (administration et posologie)</term>
<term>Antinéoplasiques alcoylants (administration et posologie)</term>
<term>Atrophie</term>
<term>Cyclophosphamide (administration et posologie)</term>
<term>Femelle</term>
<term>Fibrose</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mastectomie partielle</term>
<term>Mitoxantrone (administration et posologie)</term>
<term>Méthode en simple aveugle</term>
<term>Pigmentation de la peau ()</term>
<term>Pigmentation de la peau (effets des radiations)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Radiothérapie adjuvante (effets indésirables)</term>
<term>Région mammaire ()</term>
<term>Région mammaire (effets des radiations)</term>
<term>Sujet âgé</term>
<term>Traitement médicamenteux adjuvant (effets indésirables)</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Télangiectasie ()</term>
<term>Télangiectasie (étiologie)</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Antineoplastic Agents, Alkylating</term>
<term>Cyclophosphamide</term>
<term>Mitoxantrone</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Antinéoplasiques alcoylants</term>
<term>Cyclophosphamide</term>
<term>Mitoxantrone</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Chemotherapy, Adjuvant</term>
<term>Radiotherapy, Adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Telangiectasis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Breast</term>
<term>Skin Pigmentation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr">
<term>Pigmentation de la peau</term>
<term>Région mammaire</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Radiothérapie adjuvante</term>
<term>Traitement médicamenteux adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Telangiectasis</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en">
<term>Breast</term>
<term>Skin Pigmentation</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en">
<term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Télangiectasie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Atrophy</term>
<term>Dose Fractionation</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Single-Blind Method</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Atrophie</term>
<term>Femelle</term>
<term>Fibrose</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mastectomie partielle</term>
<term>Méthode en simple aveugle</term>
<term>Pigmentation de la peau</term>
<term>Région mammaire</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein</term>
<term>Télangiectasie</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In 1996, a multicenter randomized study comparing after breast-conservative surgery, sequential vs concurrent adjuvant chemotherapy (CT) with radiation therapy (RT) was initiated (ARCOSEIN study). Seven hundred sixteen patients were included in this trial. After a median follow-up of 6.7 (4.3-9) years, we decided to prospectively evaluate the late effects of these two strategies.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Azria, D" sort="Azria, D" uniqKey="Azria D" first="D" last="Azria">D. Azria</name>
<name sortKey="Body, G" sort="Body, G" uniqKey="Body G" first="G" last="Body">G. Body</name>
<name sortKey="Bosset, J F" sort="Bosset, J F" uniqKey="Bosset J" first="J-F" last="Bosset">J-F Bosset</name>
<name sortKey="Calais, G" sort="Calais, G" uniqKey="Calais G" first="G" last="Calais">G. Calais</name>
<name sortKey="Favre, A" sort="Favre, A" uniqKey="Favre A" first="A" last="Favre">A. Favre</name>
<name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
<name sortKey="Garaud, P" sort="Garaud, P" uniqKey="Garaud P" first="P" last="Garaud">P. Garaud</name>
<name sortKey="Le Floch, O" sort="Le Floch, O" uniqKey="Le Floch O" first="O" last="Le Floch">O. Le Floch</name>
<name sortKey="Miny Buffet, J" sort="Miny Buffet, J" uniqKey="Miny Buffet J" first="J" last="Miny-Buffet">J. Miny-Buffet</name>
<name sortKey="Serin, D" sort="Serin, D" uniqKey="Serin D" first="D" last="Serin">D. Serin</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Toledano, A" sort="Toledano, A" uniqKey="Toledano A" first="A" last="Toledano">A. Toledano</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000489 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000489 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:16632399
   |texte=   [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:16632399" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024